Antidepressant-like activity of ellagic acid in unstressed and acute immobilization-induced stressed mice

Pharmacological Reports

Volumn 64, Issue 4, 2012, Pages 796-807

  Dhingra, Dinesh ^a   Chhillar, Ritu ^a  

^a GURU JAMBHESHWAR UNIVERSITY OF SCIENCE AND TECHNOLOGY   (India)

Author keywords

Antidepressant; Ellagic acid; Immobilization stress; Inducible NOS; Monoamines; Neuronal NOS

Indexed keywords

7 NITROINDAZOLE; AMINOGUANIDINE; ELLAGIC ACID; FENCLONINE; FLUOXETINE; NITRITE; PRAZOSIN; SULPIRIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG MECHANISM; DRUG POTENTIATION; DRUG RESPONSE; IMMOBILIZATION STRESS; LOCOMOTION; MALE; MOUSE; NONHUMAN;

EID: 84867686893     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(12)70875-7     Document Type: Article

References (43)

1. Abel EL, Bilitzke PJ: A possible alarm substance in the forced swimming test. Physiol Behav, 1990, 148, 233-239. (Pubitemid 20270233)
2. Bae JY, Choi JS, Kang SW, Lee YJ, Park J, Kang YH: Dietary compound ellagic acid alleviates skin wrinkle and inflammation induced by UV-B irradiation. Exp Dermatol, 2010, 19, e182-190.
3. Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroglu M, Deger O: Antioxidative activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord, 2001, 64, 43-51. (Pubitemid 32268670)
4. Binfaré RW, Rosa AO, Lobato KR, Santos AR, Rodrigues AL: Ascorbic acid administration produces an antidepressant-like effect: evidence for the involvement of monoaminergic neurotransmission. Prog Neuropsychopharmacol Biol Psychiatry, 2009, 33, 530-540.
5. Chao CY, Mong MC, Chan KC, Yin MC: Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice. Mol Nutr Food Res, 2010, 54, 388-395.
6. Esch T, Stefano GB, Fricchione GL, Benson H: The role of stress in neurodegenerative diseases and mental disorders. Neuro Endocrinol Lett, 2002, 23, 199-208. (Pubitemid 34741927)
7. Feng Y, Yang SG, Du XT, Zhang X, Sun XX, Zhao M, Sun GY, Liu RT: Ellagic acid promotes Ab42 fibrillization and inhibits Aβ42-induced neurotoxicity. Biochem Biophys Res Commun, 2009, 390, 1250-1254.
8. Gelenberg AJ: The prevalence and impact of depression. J Clin Psychiatry, 2010, 71, e06.
9. Gilhotra N, Dhingra D: Involvement of NO-cGMP pathway in anti-anxiety effect of aminoguanidine in stressed mice. Prog Neuropsychopharmacol Biol Psychiatry, 2009, 33, 1502-1507.
10. Gilhotra N, Jain H, Dhingra D: Differential effects of nitric oxide synthase inhibitors on anxiety in unstressed and stressed mice. Indian J Exp Biol, 2010, 48, 365-372.
11. 15N]-nitrate in biological fluids. Anal Biochem, 1982, 126, 131-138.
12. Haleem DJ: Behavioral deficits and exaggerated feedback control over raphe-hippocampal serotonin neurotransmission in restrained rats. Pharmacol Rep, 2011, 63, 888-897.
13. Han DH, Lee MJ, Kim JH: Antioxidant and apoptosis-inducing activities of ellagic acid. Anticancer Res, 2006, 26, 3601-3606. (Pubitemid 44701545)
14. Herken H, Gurel A, Selek S, Armutcu F, Ozen ME, Bulut M, Kap O et al.: Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res, 2007, 38, 247-252. (Pubitemid 46080553)
15. Khanduja KL, Gandhi RK, Pathania V, Syal N: Prevention of N-nitrosodiethylamine-induced lung tumorigenesis by ellagic acid and quercetin in mice. Food Chem Toxicol, 1999, 37, 313-318. (Pubitemid 29335758)
16. Kwak HM, Jeon SY, Sohng BH, Kim JG, Lee JM, Lee KB, Jeong HH et al.: b-Secretase (BACE1) inhibitors from pomegranate (Punica granatum) husk. Arch Pharm Res, 2005, 28, 1328-1332.
17. Kwon S, Lee B, Kim M, Lee H, Park HJ, Hahm DH: Antidepressant-like effect of the methanolic extract from Bupleurum falcatum in the tail suspension test. Prog Neuropsychopharmacol Biol Psychiatry, 2010, 34, 265-270.
18. Lee CY, Cheng HM, Sim SM: Mulberry leaves protect rat tissues from immobilization stress-induced inflammation. Biofactors, 2007, 31, 25-33. (Pubitemid 352032103)
19. Li W, Li QJ, An SC: Preventive effect of estrogen on depression-like behavior induced by chronic restraint stress. Neurosci Bull, 2010, 26, 140-146.
20. Madrigal JLM, Olivia HO, Moro MA, Lizasoain I, Lorenzo P, Castrillo A: The increase in TNF-α levels is implicated in NF-κB activation and inducible nitric oxide synthase expression in brain cortex after immobilization stress. Neuropsychopharmacology, 2002, 26, 155-163. (Pubitemid 34093078)
21. Michel TM, Frangou S, Thiemeyer D, Camara S, Jecel J, Nara K, Brunklaus A et al.: Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder - a postmortem study. Psychiatry Res, 2007, 151, 145-150. (Pubitemid 46634625)
22. Poleszak E, Wlaź P, Kedzierska E, Nieoczym D, Wyska E, Szymura-Oleksiak J, Fidecka S et al.: Immobility stress induces depression-like behavior in the forced swim test in mice: effect of magnesium and imipramine. Pharmacol Rep, 2006, 58, 746-752. (Pubitemid 44741694)
23. Porsolt RD, Bertin A, Jalfre M: Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn, 1977, 229, 327-336. (Pubitemid 8225714)
24. Rodrigues AS, da Silva GL, Mateussi AS, Fernandes ES, Miguel OG, Yunes RA: Involvement of monoaminergic system in the antidepressant-like effect of the hydroalcoholic extract of Siphocampylus verticillatus. Life Sci, 2002, 70, 1347-1358. (Pubitemid 34159092)
25. Rogerio AP, Fontanari C, Borducchi E, Keller AC, Russo M, Soares EG, Albuquerque DA, Faccioli LH: Anti-inflammatory effects of Lafoensia pacari and ellagic acid in a murine model of asthma. Eur J Pharmacol, 2008, 580, 262-270.
26. Sheikh N, Ahmad A, Siripurapu KB, Kuchibhotla VK, Singh S, Palit G: Effect of Bacopa monniera on stress induced changes in plasma corticosterone and brain monoamines in rats. J Ethnopharmacol, 2007, 111, 671-676. (Pubitemid 46617115)
27. Soh PN, Witkowski B, Olagnier D, Nicolau ML, Garcia-Alvarez M, Berry A, Benoit-Vical F: In vitro and in vivo properties of ellagic acid in malaria treatment. Antimicrob Agents Chemother, 2009, 53, 1100-1106.
28. Steru L, Chermat R, Thierry B, Simon P: The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl), 1985, 85, 367-370. (Pubitemid 15123115)
29. Suzuki E, Yagi G, Nakaki T, Kanba S, Asai M: Elevated plasma nitrate levels in depressive states. J Affect Disord, 2001, 63, 221-224. (Pubitemid 32200517)
30. Tasaki M, Umemura T, Maeda M, Ishii Y, Okamura T, Inoue T, Kuroiwa Y, Hirose M, Nishikawa A: Safety assessment of ellagic acid, a food additive, in a subchronic toxicity study using F344 rats. Food Chem Toxicol, 2008, 46, 1119-1124.
31. Thierry B, Stéru L, Simon P, Porsolt RD: The tail suspension test: ethical considerations. Psychopharmacology (Berl), 1986, 90, 284-285.
32. ThomasM, Feron O: Nitric oxide synthases: which, where, how, and why? J Clin Invest, 1997, 100, 2146-2152.
33. Tsuchiya T, Kishimoto J, Koyama J, Ozawa T: Modulatory effect of L-NAME, a specific nitric oxide synthase inhibitor, on stress-induced changes in plasma adrenocorticotropic hormone and corticosterone levels in rats: physiological significance of stress-induced NOS activation in hypothalamic-pituitary-adrenal axis. Brain Res, 1997, 776, 68-74. (Pubitemid 28018459)
34. Ueda H, Kawanishi K, Moriyasu M: Effects of ellagic acid and 2-(2,3,6-trihydroxy-4-carboxyphenyl)ellagic acid on sorbitol accumulation in vitro and in vivo. Biol Pharm Bull, 2004, 27, 1584-1587. (Pubitemid 41701644)
35. Umesalma S, Sudhandiran G: Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-κB, iNOS, COX-2, TNF-α, and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis. Basic Clin Pharmacol Toxicol, 2010, 107, 650-655.
36. Uzar E, Alp H, Cevik MU, Firat U, Evliyaoglu O, Tufek A, Altun Y: Ellagic acid attenuates oxidative stress on brain and sciatic nerve and improves histopathology of brain in streptozotocin-induced diabetic rats. Neurol Sci, 2012, 33, 567-574.
37. Volke V, Wegener G, Bourin M, Vasar E: Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2- trifluoromethylphenyl)-imidazole in mice. Behav Brain Res, 2003, 140, 141-147. (Pubitemid 36313249)
38. Wang D, An SC, Zhang X: Prevention of chronic stress-induced depression-like behavior by inducible nitric oxide inhibitor. Neurosci Lett, 2008, 433, 59-64.
39. Willner P: The validity of animal models of depression. Psychopharmacology, 1984, 83, 1-16.
40. Wong ML, Licinio J: Research and treatment approaches to depression. Nat Rev Neurosci, 2001, 2, 343-351.
41. Yildiz F, Erden BF, Ulak G, Utkan T, Gacar N: Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats. Psychopharmacology (Berl), 2000, 149, 41-44. (Pubitemid 30187365)
42. Yu ZF, Kong LD, Chen Y: Antidepressant activity of aqueous extracts of Curcuma longa in mice. J Ethnopharmacol, 2002, 83, 161-165. (Pubitemid 36164742)
43. Zaidi SM, Al Qirim TM, Hoda N, Banu N: Modulation of restraint stress induced oxidative changes in rats by antioxidants vitamins. J Nutr Biochem, 2003, 14, 633-636. (Pubitemid 37415265)